Advisory Notes

(Ottawa, ON – April 14, 2015) – The Canadian Centre for Ethics in Sport (CCES) wishes to advise the Canadian sport community of three important updates related to the 2015 Canadian Anti-Doping Program (CADP) pertaining to athletes with a disability and the use of catheters.

(Ottawa, ON – December 22, 2014) – The Canadian Centre for Ethics in Sport (CCES) wishes to advise the Canadian sport community that the language in Clause 4 of the Athlete Contract has been adjusted to more clearly reflect the purpose for the disclosure and to clarify to National Athlete Pool (NAP) athletes that the information to be disclosed must be directly related to potential anti-doping rule violations as described in the Canadian Anti-Doping Program (CADP).

(Ottawa, Ontario – June 18, 2014) – The Canadian Centre for Ethics in Sport (CCES) would like to alert the Canadian sport community that the World Anti-Doping Agency (WADA) has made amendments to Section S.2.1 of the 2014 Prohibited List.

(Ottawa, Ontario – October 29, 2013) – The Canadian Centre for Ethics in Sport (CCES) would like to alert the sport community about the findings of a study conducted by NSF International, Harvard Medical School and the National Institute for Public Health and Environment, on a nutritional supplement called Craze.

(Ottawa, Ontario – December 6, 2012) – The Canadian Centre for Ethics in Sport (CCES) warns once again of the link between supplement products and positive doping tests. We would like to highlight a recent doping case to illustrate to athletes and their support personnel how supplements and sport nutrition products can pose a real risk of a positive test.

(Ottawa, Ontario – March 1, 2012) – The Canadian Centre for Ethics in Sport (CCES) advises athletes and support personnel that supplements and sport nutrition products continue to be the source of doping violations, around the world and here at home.

(Ottawa, Ontario – June 23, 2011) – The Canadian Centre for Ethics in Sport has begun to monitor athletes’ sample analysis results over time. This innovative development, known as a biological passport, is recognized as the most promising way forward for anti-doping organizations in the fight against doping.

(Ottawa, Ontario – November 15, 2010) – The Canadian Centre for Ethics in Sport (CCES) advises athletes and support personnel that supplements containing the banned stimulant methylhexaneamine are widely available in the Canadian market and have been the source of many doping violations worldwide over the last year.

(Ottawa, Ontario – January 5, 2010) – The Canadian Centre for Ethics in Sport (CCES) would like to remind the Canadian sport community that the World Anti-Doping Agency (WADA) has reintroduced pseudoephedrine to the Prohibited List effective January 1, 2010.

(Ottawa, Ontario – August 11, 2009) – The Canadian Centre for Ethics in Sport (CCES) is resuming blood testing, complementing the use of urine analysis in an increasingly robust anti-doping program.

(Ottawa, Ontario – September 26, 2007) – The Canadian Centre for Ethics in Sport (CCES) would like to alert the sport community that intravenous infusions are prohibited in sport, except as a legitimate medical treatment.

(Ottawa, Ontario – July 13, 2007) – Health Canada issued an advisory earlier this week to warn consumers against a dietary supplement called MdMt, or any other supplements containing the synthetic steroids methyl-1-testosterone or methyldienolone.

(Ottawa, Ontario – October 4, 2006) – The Canadian Centre for Ethics in Sport (CCES) supports the decision of the World Anti-Doping Agency (WADA) that hypoxic devices should not be added to the 2007 Prohibited List.

(Ottawa, Ontario – May 23, 2006) – Health Canada recently issued an advisory to warn consumers about five products containing illegal anabolic steroids: Anabolic Xtreme Superdrol, Methyl-1-P, Ergomax LMG, Prostanozoland, and FiniGenX Magnum Liquid.

(Ottawa, Ontario – February 23, 2006) – Health Canada recently issued an advisory to warn consumers not to use supplements containing methyl-1-testosterone, including the product M1T Andro Technologies.

(Ottawa, Ontario – October 18, 2005) – Members of the Canadian sport community who require asthma medication should review the Health Canada advisory issued October 4, 2005, which warns of risks associated with a class of asthma drugs.

(Ottawa, Ontario – May 6, 2005) – In light of recent media announcements regarding a report by Canadian food inspectors that finds most sport nutrition products break federal regulations, the CCES would like to remind athletes and the sport community to seek professional advice before consuming supplements and sports foods.

(Ottawa, Ontario – June 14, 2004) – On May 30-31, 2004, international delegates met in Montreal, Canada, to contend with the issue of nutritional supplement use and misuse in sport by athletes.